The Cannabis Oil Company (TCOC) has an ethically-led team, based in the UK. TCOC are now seeking investment to fund the production and manufacturing of high-quality CBD products, and to carry out in-depth research into the benefits of CBD for specific ailments and illnesses.
TCOC aims to provide high-quality CBD products with end-to-end traceability. With the support of the medical expertise on the team, we intend to conduct medical studies for the treatment of conditions such as epilepsy.
Once products have been launched, we plan to provide full transparency as to the quality of our products via on-going testing and implementation of the results, ensuring that the business can be relied upon as a beacon of credibility within the industry. With the use of established facilities, high-quality medicinal CBD will be UK grown and manufactured.
We are building an online community for consumers with a third party to discuss their experiences & the benefits they have encountered with using CBD products.
TCOC are members of the Centre for Medicinal Cannabis UK. Being aligned with this organisation increases the capability to engage intelligently & strategically with all influential political & public policy stakeholders as well as relevant regulatory bodies.
We are frustrated with the market leaders and their lack of investment in the industry. As a result, we intend to invest in trials to help develop the understanding of the benefits of CBD and aim to be at the forefront of any change in regulation.
The CBD market is forecast to exceed £1.6 bn in the next 12 months and £15 bn by 2022. We are seeking to become the market leaders here in the UK.